RHL Group’s Merck MRK Stock Holding History

RHL Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64.5K	Sell	500 -21,497	-98%	-$2.52M	0.05%	83
2026 Q1	$2.65M	Buy	21,997 +4,002	+22%	+$462K	2.26%	9
2025 Q4	$1.89M	Buy	+17,995	New	+$1.69M	1.52%	10

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RHL Group's MRK Position: Q2 2026 in Review

RHL Group reduced its Merck (MRK) stake by 98% in Q2 2026, selling an estimated $2.52M and leaving 500 shares worth $64.5K. The position accounts for 0.05% of the portfolio, ranked #83.

RHL Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.65M in Q1 2026. 3,828 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

RHL Group held 500 shares of Merck worth $64.5K as of Q2 2026.
RHL Group sold 21,497 Merck shares in Q2 2026, an estimated $2.52M.
Merck made up 0.05% of RHL Group's portfolio in Q2 2026, its #83 holding.
RHL Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
RHL Group's Merck position peaked at $2.65M in Q1 2026.
3,828 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on RHL Group's 13F filing for Q2 2026, filed 4 Aug 2026.